Can Neurologists Predict Long-Term Disability Trajectories in Primary Progressive MS?September 30, 2016Multiple Sclerosis
Alemtuzumab, natalizumab found equally effective for relapsing-remitting MSSeptember 22, 2016Multiple Sclerosis
Ocrelizumab Increases Likelihood of No Evidence of Disease Progression September 20, 2016Multiple Sclerosis
Arbaclofen Extended-Release Tablets Are Effective for MS SpasticitySeptember 20, 2016Multiple Sclerosis
Siponimod curbs disability in secondary progressive multiple sclerosisSeptember 20, 2016Multiple Sclerosis
Durable Efficacy of Alemtuzumab: Five-Year Follow-Up of the CARE-MS StudiesSeptember 16, 2016Multiple Sclerosis
Does the EDSS Capture Cognitive Difficulties in Patients With MS? September 16, 2016Multiple Sclerosis
Can Neurologists Predict Long-Term Disability Trajectories in Primary Progressive MS?September 16, 2016Multiple Sclerosis
Telerehabilitation May Be As Effective As In-Person Rehabilitation in MSSeptember 15, 2016Multiple Sclerosis
